March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Limk2 Controls Epithelial Sheet Migration During Eyelid Development
Author Affiliations & Notes
  • Dennis S. Rice
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Matthew M. Newhouse
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • David Potter
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Mike J. Crist
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Nianhua Xu
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Gwenn M. Hansen
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Alejandro Abuin
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Brian P. Zambrowicz
    Ophthalmology, Lexicon Pharmaceuticals Inc, The Woodlands, Texas
  • Peter J. Vogel
    St Jude Children's Research Hospital, Memphis, Tennessee
  • Footnotes
    Commercial Relationships  Dennis S. Rice, Lexicon Pharmaceuticals (E); Matthew M. Newhouse, Lexicon Pharmaceuticals (E); David Potter, Lexicon Pharmaceuticals (E); Mike J. Crist, Lexicon Pharmaceuticals (E); Nianhua Xu, Lexicon Pharmaceuticals (E); Gwenn M. Hansen, Lexicon Pharmaceuticals (E); Alejandro Abuin, Lexicon Pharmaceuticals (E); Brian P. Zambrowicz, Lexicon Pharmaceuticals (E); Peter J. Vogel, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4914. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dennis S. Rice, Matthew M. Newhouse, David Potter, Mike J. Crist, Nianhua Xu, Gwenn M. Hansen, Alejandro Abuin, Brian P. Zambrowicz, Peter J. Vogel; Limk2 Controls Epithelial Sheet Migration During Eyelid Development. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4914.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Genetic disruption of several genes involved in actin cytoskeleton remodeling induces an eyes open at birth (EOB) phenotype. We have used retroviral gene trapping to disrupt the expression of all known isoforms of LIM motif-containing protein kinase 2 (Limk2). Limk2 regulates the biochemical function of actin binding proteins such as cofilin. Mice deficient in Limk2 (Limk2-/-) exhibit an EOB phenotype. The purpose of this study is to investigate the molecular mechanisms associated with the EOB phenotype.

Methods: : Histology was performed on embryos and postnatal mice at relevant stages of eyelid development. In situ hybridization, immunohistochemistry and immunoblotting techniques were used to investigate Limk2 expression and function during eyelid development.

Results: : The EOB phenotype is fully penetrant in Limk2-/- mice, whereas eyelid development is comparable between wild type (Limk2+/+) and heterozygous (Limk2 +/-) mice. Limk2 is expressed in palpebral epidermis and conjunctiva during eyelid formation. Periderm cells also express high levels of Limk2. The EOB phenotype becomes apparent at E15.5 in Limk2-/- mice, when the epithelial sheet fails to migrate over the corneal surface. Levels of phospho-cofilin, a biochemical substrate of Limk2, and of F-actin are decreased in the Limk2-/- eyelids.

Conclusions: : Inactivation of Limk2 results in an EOB phenotype. This phenotype arises through failure in epithelial sheet migration associated with decreased levels of F-actin. Decreased levels of F-actin presumably arise as a result of the increased actin-severing activity of non-phosphorylated cofilin in the knockout eyelid. These results demonstrate that proper eyelid development requires F-actin nucleation in migrating epithelial cells.

Keywords: cytoskeleton • development • eyelid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×